Marcello Cattani, President of Farmindustria, has been awarded the “Academy Leaders” prize by the Academy for Health and Clinical Research. The award ceremony took place at the Guglielmo Marconi University in Rome and recognized individuals who have made significant contributions in the fields of Science, Society, Health, Sports, Culture, and Entertainment.
Cattani expressed his gratitude for the recognition and emphasized the importance of innovation in the pharmaceutical industry. He stated that the award shines a light on an industry that thrives on innovation to provide better healthcare solutions. Cattani acknowledged the efforts of all the workers in pharmaceutical companies who strive to ensure the health of citizens on a daily basis.
In his acceptance speech, Cattani highlighted the need for innovation to be the guiding principle for the industry. He emphasized that in a world of global competition, it is essential to keep pace with other leading countries. The pharmaceutical industry in Italy has the potential to become even more attractive and contribute significantly to the nation’s economy. Cattani mentioned that in 2023 alone, the industry generated over 50 billion euros, with more than 90% of this revenue coming from exports. This highlights Italy’s position as a leader in the European Union and its contribution to the country’s GDP, accounting for 2%.
Moreover, Cattani underscored the industry’s impact on local communities. The pharmaceutical sector invests 3.5 billion euros in production and research and development, representing a 22% increase in the past five years. This not only benefits the economy but also creates employment opportunities. Currently, there are nearly 70,000 highly skilled employees in the industry, with a 9% increase in the past five years. Notably, there has been a significant rise in the number of young professionals and women, with an increase of 15%.
Cattani also highlighted the industry’s commitment to gender equality. Women represent 44% of the total workforce, 46% of managers and executives, and 53% in research and development. Furthermore, he emphasized the industry’s dedication to education and training, particularly for young people in secondary schools, technical institutes, and universities. The focus is on equipping them with the necessary skills for emerging job profiles. Additionally, Cattani mentioned the industry’s efforts to promote work-life balance and welfare measures for its employees.
The “Academy Leaders” prize aims to honor individuals who have made significant contributions and have demonstrated a commitment to innovation and creating a better future. The inaugural ceremony was attended by prominent figures such as Marco Abate, Rector of the Guglielmo Marconi University, Alesso Acomanni, President of the University’s Board of Directors, and Roberto Verna, President of the Academy for Health and Clinical Research. Verna presented the motivations behind the award and handed out the prizes alongside other members of the Academy.
In conclusion, Marcello Cattani’s recognition as the recipient of the “Academy Leaders” prize highlights the accomplishments and potential of the pharmaceutical industry in Italy. The industry’s commitment to innovation, economic growth, employment, gender equality, education, and employee welfare makes it a crucial player in the country’s development. The award serves as a testament to the industry’s dedication to improving healthcare and generating new perspectives for the future.